Humana (NYSE:HUM) Issues FY24 Earnings Guidance

Humana (NYSE:HUMGet Free Report) issued an update on its FY24 earnings guidance on Monday morning. The company provided EPS guidance of ~$16.00 for the period, compared to the consensus EPS estimate of $16.37.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the stock. The Goldman Sachs Group decreased their target price on shares of Humana from $450.00 to $385.00 and set a buy rating on the stock in a research report on Wednesday, April 3rd. Barclays decreased their target price on shares of Humana from $356.00 to $310.00 and set an equal weight rating on the stock in a research report on Tuesday, April 2nd. Wells Fargo & Company decreased their target price on shares of Humana from $413.00 to $350.00 and set an overweight rating on the stock in a research report on Monday, April 8th. Royal Bank of Canada decreased their target price on shares of Humana from $415.00 to $353.00 and set an outperform rating on the stock in a research report on Thursday, April 25th. Finally, Cantor Fitzgerald reduced their price target on shares of Humana from $391.00 to $360.00 and set a neutral rating on the stock in a research report on Thursday, April 25th. Thirteen analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of Hold and an average target price of $423.63.

Read Our Latest Stock Analysis on Humana

Humana Stock Performance

Shares of HUM stock opened at $360.87 on Wednesday. The firm has a market cap of $43.48 billion, a price-to-earnings ratio of 22.47, a P/E/G ratio of 2.14 and a beta of 0.53. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.67 and a current ratio of 1.67. Humana has a 52 week low of $298.61 and a 52 week high of $530.54. The firm’s 50-day simple moving average is $330.26 and its two-hundred day simple moving average is $365.13.

Humana (NYSE:HUMGet Free Report) last announced its quarterly earnings results on Wednesday, April 24th. The insurance provider reported $7.23 EPS for the quarter, beating analysts’ consensus estimates of $6.12 by $1.11. The company had revenue of $29.61 billion for the quarter, compared to analysts’ expectations of $28.52 billion. Humana had a net margin of 1.82% and a return on equity of 17.76%. Humana’s revenue was up 10.7% compared to the same quarter last year. During the same period in the prior year, the company posted $9.38 EPS. As a group, equities analysts forecast that Humana will post 16 earnings per share for the current year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 0.98%. The ex-dividend date is Friday, June 28th. Humana’s dividend payout ratio is presently 22.04%.

About Humana

(Get Free Report)

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

See Also

Earnings History and Estimates for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.